Rutgers Study Links GLP-1 Drugs to Reduced Impulsivity Amid Historic US Crime Drop
A Rutgers University study suggests weight-loss drugs like Ozempic may contribute to the US's historic decline in violent crime by reducing impulsivity and alcohol use. While criminologists debate the causes of the 9.7% drop in violent crime in 2025, this research indicates that GLP-1 medications alter brain reward processing, potentially lowering the likelihood of violent behavior among the 15% of adults currently using these drugs.
Key points
- Rutgers sociology professor Daniel Semenza found that current GLP-1 users exhibit lower levels of impulsivity and alcohol consumption, two established risk factors for violence.
- The study suggests GLP-1 medications affect brain regions involved in reward processing and self-regulation, potentially dampening the link between impulsive urges and violent actions.
- Approximately 15% of American adults are currently taking GLP-1 medications for weight loss or chronic conditions, representing a significant portion of the population.
- Semenza emphasizes that the research shows a correlation between reduced risk factors and violence, not a direct causal link between the drugs and national crime statistics.
- The findings are part of a broader effort to understand the unprecedented 9.7% drop in US violent crime in 2025, the largest annual decline since national estimates began in 1936.
Background
This development follows the FBI's 2025 data, which recorded the largest annual drop in violent crime since 1936, with murder rates tying lows from 1955-1956. While previous analyses attributed this decline to post-pandemic normalization, demographic shifts, and improved policing technology, the new Rutgers study introduces a pharmacological variable. It suggests that the widespread adoption of GLP-1 drugs may be influencing behavioral outcomes, adding a new dimension to the discussion on crime prevention strategies.
Why it matters
If GLP-1 medications are confirmed to reduce violent behavior through impulse control, this could reshape public health and criminal justice strategies. Understanding the intersection between medical treatments and social outcomes may lead to new approaches in violence prevention, potentially leveraging existing healthcare interventions to address societal safety issues.
What to watch
Researchers call for longitudinal studies to track individuals before, during, and after GLP-1 treatment to determine long-term effects on behavior. Future research will need to establish whether the observed correlations translate into direct causal effects on crime rates, moving beyond current observational data.
Want the full story? Read the original reporting
Read on New York Post